Opposition renews calls to fund meningococcal B vaccine as WA hits seven cases of deadly disease
The latest case of the uncommon but life-threatening bacterial infection, diagnosed in a child who is now recovering in hospital, brought the total in line with the State's five-year average.
It prompted shadow health minister Libby Mettam to urge the Minister for Preventative Health to consider a free vaccination program for MenB in Budget Estimates on Wednesday.
A combined vaccine for A, C, W and Y strains is free via the National Immunisation Program for all children aged 12 months, but the immunisation to protect against the B strain is not.
Immunising against MenB is currently a costly exercise in WA with two doses of the jab costing between $320 to $350.
It is only free for First Nations children and other children with specified conditions.
When urged to consider a free vaccination program in Budget Estimates, Preventative Health Minister Sabine Winton said WA Health were closely monitoring cases.
'The Department of Health and the Communicable Disease Control Directorate closely monitor all those serious notifiable diseases, including meningococcal,' she said.
'They continue to provide advice to ministers, including me, regarding the requirements relating to meningococcal B and other strains.
'I will continue to monitor the trends in relation to MenB and seek advice from experts around Western Australia's future response.'
WA Department of Health director-general Shirley Bowen said a vaccination program would be considered if there were clusters of MenB in the community.
'Seven is a number that concerns us definitely,' she said.
'We have a very active and watching brief on this situation and we will consider it at any time should we see significant clusters of meningococcal B occurring.
'At the moment, we are not seeing significant clusters. We are just seeing the occasional case but we definitely recognise it is an important and preventable disease and we will continue to watch it actively.'
At a press conference on Tuesday, Ms Mettam said the strain B vaccine 'represents extraordinary bang for buck because it ultimately saves lives'.
'Meningococcal B is a serious life threatening condition but there is a way to prevent it and that is through the roll out of a free vaccination, something that we have seen in other states,' she said.
'The Cook Labor government can do this.'
Meningitis Centre chief executive Karen Quick backed the call for MenB vaccinations to be made free.
'South Australia, Queensland and the Northern Territory have all gone ahead as they're not prepared to take a gamble with their children's lives,' she said.
'Western Australia can do exactly the same thing. It's not fair, it's not equitable that the states across our borders get vaccinated and yet our children here in WA don't.
'Vaccines are no good sitting on shelves. They need to be in our children's arms to protect them.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
18 hours ago
- News.com.au
WA Health issues urgent warning after reports wrong vaccine jabs given to patients by medical staff
Medical staff in Western Australia have been warned after reports of the wrong immunisations being given to patients. The West Australian reports a vaccine update was sent to medical offices in the western state on Thursday reminding staff to make sure they are giving patients the right jab for respiratory syncytial virus (RSV). 'It is essential to check the correct RSV immunisation product is being given prior to administration,' WA Health said. 'Recent reporting to the Australian Immunisation Register and Western Australia Vaccine Safety Surveillance System has indicated that some Respiratory Syncytial Virus immunisation products have been administered incorrectly.' In the alert, WA Health urged staff to use the correct products according to the Australian Immunisation Handbook NewsWire has contacted WA Health for further comment. There are different types of RSV jabs for particular demographics. Beyfortus (nirsevimab) can be given to children aged up to two-years-old, while Abrysvo is a vaccine registered for women who are 28-36 weeks pregnant and for adults over the age of 60. Another vaccine, Arexvy, is registered for adults over 60, or adults over 50 with increased risk. The Therapeutic Goods Administration (TGA) recently released advice on the 'correct administration' of RSV vaccines, which was released in response to reports of administration errors. 'We have been receiving reports in 2025 of product administration errors related to RSV prevention products,' the TGA's advice states. 'No adverse event was reported for most of the product administration error reports received by the TGA to date, but an administration error may lead to various problems, including unknown levels of protection for vaccine recipients. 'The potential consequences of these errors could include inadequate immunological protection, cost impacts, inconvenience and reduced confidence in vaccination more broadly.' According to the TGA this year there have been 24 medication error reports of Arexvy being given in pregnancy, 24 reports of Abrysvo being administered to children less than 12 months old, and 36 reports of Beyfortus (nirsevimab) being administered to females aged 15–54 years.
Perth Now
18 hours ago
- Perth Now
Major warning after wrong vaccines given
Medical staff in Western Australia have been warned after reports of the wrong immunisations being given to patients. The West Australian reports a vaccine update was sent to medical offices in the western state on Thursday reminding staff to make sure they are giving patients the right jab for respiratory syncytial virus (RSV). 'It is essential to check the correct RSV immunisation product is being given prior to administration,' WA Health said. 'Recent reporting to the Australian Immunisation Register and Western Australia Vaccine Safety Surveillance System has indicated that some Respiratory Syncytial Virus immunisation products have been administered incorrectly.' WA Health issued an urgent alert to staff after receiving reports the wrong RSV vaccines had been administered to some patients. NewsWire / David Crosling Credit: News Corp Australia In the alert, WA Health urged staff to use the correct products according to the Australian Immunisation Handbook NewsWire has contacted WA Health for further comment. There are different types of RSV jabs for particular demographics. Beyfortus (nirsevimab) can be given to children aged up to two-years-old, while Abrysvo is a vaccine registered for women who are 28-36 weeks pregnant and for adults over the age of 60. Another vaccine, Arexvy, is registered for adults over 60, or adults over 50 with increased risk. Medical staff were urged to keep a closer eye on what jabs they are giving. NewsWire/Ian Currie Credit: News Corp Australia The Therapeutic Goods Administration (TGA) recently released advice on the 'correct administration' of RSV vaccines, which was released in response to reports of administration errors. 'We have been receiving reports in 2025 of product administration errors related to RSV prevention products,' the TGA's advice states. 'No adverse event was reported for most of the product administration error reports received by the TGA to date, but an administration error may lead to various problems, including unknown levels of protection for vaccine recipients. Nationwide there have been 84 reports of the wrong vaccine being given. NCA NewsWire / David Crosling Credit: News Corp Australia 'The potential consequences of these errors could include inadequate immunological protection, cost impacts, inconvenience and reduced confidence in vaccination more broadly.' According to the TGA this year there have been 24 medication error reports of Arexvy being given in pregnancy, 24 reports of Abrysvo being administered to children less than 12 months old, and 36 reports of Beyfortus (nirsevimab) being administered to females aged 15–54 years.
West Australian
a day ago
- West Australian
Opposition renews calls to fund meningococcal B vaccine as WA hits seven cases of deadly disease
The Opposition has renewed calls to fund the meningococcal B vaccine after six of seven recorded cases of the deadly disease this year were identified as the strain. The latest case of the uncommon but life-threatening bacterial infection, diagnosed in a child who is now recovering in hospital, brought the total in line with the State's five-year average. It prompted shadow health minister Libby Mettam to urge the Minister for Preventative Health to consider a free vaccination program for MenB in Budget Estimates on Wednesday. A combined vaccine for A, C, W and Y strains is free via the National Immunisation Program for all children aged 12 months, but the immunisation to protect against the B strain is not. Immunising against MenB is currently a costly exercise in WA with two doses of the jab costing between $320 to $350. It is only free for First Nations children and other children with specified conditions. When urged to consider a free vaccination program in Budget Estimates, Preventative Health Minister Sabine Winton said WA Health were closely monitoring cases. 'The Department of Health and the Communicable Disease Control Directorate closely monitor all those serious notifiable diseases, including meningococcal,' she said. 'They continue to provide advice to ministers, including me, regarding the requirements relating to meningococcal B and other strains. 'I will continue to monitor the trends in relation to MenB and seek advice from experts around Western Australia's future response.' WA Department of Health director-general Shirley Bowen said a vaccination program would be considered if there were clusters of MenB in the community. 'Seven is a number that concerns us definitely,' she said. 'We have a very active and watching brief on this situation and we will consider it at any time should we see significant clusters of meningococcal B occurring. 'At the moment, we are not seeing significant clusters. We are just seeing the occasional case but we definitely recognise it is an important and preventable disease and we will continue to watch it actively.' At a press conference on Tuesday, Ms Mettam said the strain B vaccine 'represents extraordinary bang for buck because it ultimately saves lives'. 'Meningococcal B is a serious life threatening condition but there is a way to prevent it and that is through the roll out of a free vaccination, something that we have seen in other states,' she said. 'The Cook Labor government can do this.' Meningitis Centre chief executive Karen Quick backed the call for MenB vaccinations to be made free. 'South Australia, Queensland and the Northern Territory have all gone ahead as they're not prepared to take a gamble with their children's lives,' she said. 'Western Australia can do exactly the same thing. It's not fair, it's not equitable that the states across our borders get vaccinated and yet our children here in WA don't. 'Vaccines are no good sitting on shelves. They need to be in our children's arms to protect them.'
